定量的超音波パラメータが肺疾患診断の新たなツールとなる(Quantitative Ultrasound Parameters Offer New Tool for Diagnosing Lung Disease)

ad

2024-08-13 ノースカロライナ州立大学(NCState)

研究者たちは、超音波を用いて肺のさまざまな物理的特性を定量的に測定するパラメータを確立し、動物モデルで肺疾患の診断と重症度の評価に成功しました。この研究では、肺の微細構造や弾性、液体量などを測定し、それらのパラメータを組み合わせることで疾患の存在と重症度を示すバイオマーカースコアを生成します。5つのパラメータが肺線維症と浮腫の評価に必要であり、感度と特異性の両方が高い診断ツールとして期待されています。

<関連情報>

肺の定量的超音波検査による間質性肺疾患の病期分類とモニタリング Lung quantitative ultrasound to stage and monitor interstitial lung diseases

Azadeh Dashti,Roshan Roshankhah,Theresa Lye,John Blackwell,Stephanie Montgomery,Thomas Egan,Jonathan Mamou & Marie Muller
Scientific Reports  Published:16 July 2024
DOI:https://doi.org/10.1038/s41598-024-66390-6

定量的超音波パラメータが肺疾患診断の新たなツールとなる(Quantitative Ultrasound Parameters Offer New Tool for Diagnosing Lung Disease)

Abstract

Chronic interstitial lung diseases (ILDs) require frequent point-of-care monitoring. X-ray-based methods lack resolution and are ionizing. Chest computerized tomographic (CT) scans are expensive and provide more radiation. Conventional ultrasound can detect severe lung damage via vertical artifacts (B-lines). However, this information is not quantitative, and the appearance of B-lines is operator- and system-dependent. Here we demonstrate novel ultrasound-based biomarkers to assess severity of ILDs. Lung alveoli scatter ultrasound waves, leading to a complex acoustic signature, which is affected by changes in alveolar density due to ILDs. We exploit ultrasound scattering in the lung and combine quantitative ultrasound (QUS) parameters, to develop ultrasound-based biomarkers that significantly correlate (p = 1e-4 for edema and p = 3e-7 for fibrosis) to the severity of pulmonary fibrosis and edema in rodent lungs. These innovative QUS biomarkers will be very significant for monitoring severity of chronic ILDs and response to treatment, especially in this new era of miniaturized and highly portable ultrasound devices.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました